Metastasis of Prostate Adenocarcinoma to the Orbit: A case report
Abstract
Prostate cancer is the second most common malignancy after skin cancer, and second leading cause of cancer death in western countries. However its incidence and mortality is lower among Iranian population. At the time of diagnosis, about 30% of patient have regional or distant metastasis. Orbital metastasis is uncommon in adult and represents only 2-9% of orbital tumors. We present a case of prostate adenocarcinoma with metastasis to the left orbital cavity from the Cancer Institute of Iran. The patient was a 62-years old man, with known adenocarcinoma of prostate from 2011 was referred to the Cancer Institute of Iran in March 2013. He was suffering from progressive left eye vision loss, proptosis, a growing mass in the left orbit, diplopia, headache, and generalized bone pain.Core needle biopsy from the mass revealed moderately differentiated adenocarcinoma. The patient was discussed at the tumor board on March 2013. The board recommended palliative radiation to the orbit, effective pain control regimen, and other necessary measures. Due to poor general condition, orbital radiotherapy was not possible, but he received other palliative measures. The disease was progressed and patients passed away within 2 months. Orbital metastasis of prostate cancer is very rare. Prognosis is usually poor and the treatment depends on the level of extension and general condition of the patients.Bray F., Lortet-Tieulent J., Ferlay J., Forman D., Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: An overview. EUROPEAN JOURNAL OF CANCER 4 6 , 2 0 1 0 : 3 0 4 0 –3 0 5 2.
E. Surveillance End Results (SEER) Program, the National Cancer for Health Statistics. SEER stat fact sheets: prostate. http://seer. cancer.gov/statfacts/html/prost.html; 2012
Sadjadi A., Nooraie M., Ghorbani A., Alimohammadian M., Zahedi MJ. , Darvish-Moghadam S., et al. The Incidence of Prostate Cancer in Iran: Results of a Population-Based Cancer Registry. Arch Iranian Med 2007; 10 (4): 481 – 485.
Uluocak N, Suha Parlaktas B, Ersay Deniz F, Erdemir F, Dogan Koseoglu R, Gedar MO. Orbital Metastasis of Prostate Cancer: A Case Report. The Kaohsiung Journal of Medical Sciences. 2007; 23(4):199-202.
Challagundla S, Gokden M, Viswamitra S, Kohli M. Orbital metastasis from prostate cancer: an atypical case of neuroendocrine dedifferentiation during progression from hormone-sensitive to refractory stage. Clin Prostate Cancer. 2005;4(2):134-7.
Humphrey PA. Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol. 2007;60(1):35-42.
Abrahamsson P-A. Pathophysiology of Bone Metastases in Prostate Cancer. European Urology Supplements. 2004;3(5):3-9.
Kattah JC, Chrousos GC, Roberts J, Kolsky M, Zimmerman L, Manz H. Metastatic prostate cancer to the optic canal. Ophthalmology. 1993;100(11):1711-5.
Darsaut TE, Lanzino G, Lopes MB, Newman S. An introductory overview of orbital tumors. Neurosurg Focus. 2001;10(5).
Patel AR, Olson KB, Pienta KJ. Proptosis and decreased vision secondary to prostate cancer orbital wall metastasis. Anticancer Res. 2005;25(5):3521-2.
Kancherla S., G. Bianciotto C., L. Shields C. Prostate Carcinoma, a Common Cancer in Men, Rarely Metastasizes to the Eye. Retina Today I, 2011.
Files | ||
Issue | Vol 7 No 1 (2015) | |
Section | Case Reports | |
Keywords | ||
Prostate Cancer Orbital metastasis Cancer in Iran |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |